$41.78
-1.27-2.95%
Virtus Biotech Clinical Trials ETF (BBC) Stock Price, Quote, News & History
BBCARCA
Alumis Inc. is drawing attention with a major share sale and bullish analyst forecasts. The firm aims to fund its immune disease pipeline.
You can purchase shares of Virtus Biotech Clinical Trials ETF (ARCA:BBC) through any online brokerage.
There are no as such competitors for Virtus Biotech Clinical Trials ETF.
There is no analysis for Virtus Biotech Clinical Trials ETF to provide a consensus price target.
The stock price for Virtus Biotech Clinical Trials ETF (ARCA: BBC) is $ last updated .
There are no upcoming dividends for Virtus Biotech Clinical Trials ETF.
Virtus Biotech Clinical Trials ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Virtus Biotech Clinical Trials ETF.
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary...
